gilotrif.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: | ||
Meta Tags
| Title | Patient and Caregiver Information | Gilotrif® (afatinib) |
| Description | If you have been prescribed GILOTRIF, you are not If you’ve been diagnosed with advanced Non-Small Cell Lung Cancer (NSCLC) with common EGFR mutations (Del19 or L858R), take the time to learn more about your condition and treatment options. GILOTRIF is a prescription medicine used to treat people |
| Keywords | gilotrif, boehringer-ingelheim, boehringer-ingleheim, böhringer-ingelheim, boehringer, böhringer, ingelheim |
Server Information
| WebSite | |
| Host IP | 45.60.109.115 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
gilotrif.com Valuation
|
US$9,327,284
Last updated: 2022-08-20 19:35:55
gilotrif.com has Semrush global rank of 1,134,768. gilotrif.com has an estimated worth of US$ 9,327,284, based on its estimated Ads revenue. gilotrif.com receives approximately 1,076,226 unique visitors each day. Its web server is located in United States, with IP address 45.60.109.115. According to SiteAdvisor, gilotrif.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$9,327,284 |
| Daily Ads Revenue | US$8,610 |
| Monthly Ads Revenue | US$258,295 |
| Yearly Ads Revenue | US$3,099,529 |
| Daily Unique Visitors | 71,749 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| gilotrif.com. | A | 300 | IP: 45.60.109.115 |
| gilotrif.com. | A | 300 | IP: 45.60.73.115 |
| gilotrif.com. | NS | 43200 | NS Record: nsb.perf1.com. |
| gilotrif.com. | NS | 43200 | NS Record: nsa.perf1.fr. |
| gilotrif.com. | NS | 43200 | NS Record: nsc.perf1.com. |
| gilotrif.com. | MX | 43200 | MX Record: 0 mx3.nameshield.com. |
| gilotrif.com. | MX | 43200 | MX Record: 10 mx4.nameshield.net. |
| gilotrif.com. | TXT | 43200 | TXT Record: facebook-domain-verification=vmcdbqx2k9ultibcefjeboanpf98xz |
| gilotrif.com. | TXT | 43200 | TXT Record: v=spf1 include:_spf.boehringer-ingelheim.com -all |
| gilotrif.com. | TXT | 43200 | TXT Record: _globalsign-domain-verification=k_URN5sk-BJy4wlDWlaCtPxKZipt3rDs4F3YwltNmy |
| gilotrif.com. | TXT | 43200 | TXT Record: google-site-verification=X-YRUrMchll8ux15oiD1uXOeC0rKwNKtCRlW1I4mmsA |
HtmlToTextCheckTime:2022-08-20 19:35:55
| Click here to read Boehringer Ingelheim’s update on COVID-19 Healthcare Professionals GILOTRIF Patient Services --> Important Safety Information Indication Prescribing Information Important Safety Information Indication Indication GILOTRIF is a prescription medicine that is used to treat people with non-small cell lung cancer (NSCLC) that: has certain (non-resistant) abnormal epidermal growth factor receptor (EGFR) gene(s). Your healthcare provider will perform a test to make sure that GILOTRIF is right for you. has spread to other parts of the body (metastatic), and has not been previously treated for metastatic lung cancer It is not known if GILOTRIF is safe and effective in treating people with lung cancer that has resistant abnormal EGFR genes. or is used to treat people with squamous cell lung cancer that: has spread to other parts of the body, and has been previously treated with chemotherapy that contains platinum. It is not known if GILOTRIF is safe and effective in |
HTTP Headers
HTTP/1.1 308 Permanent Redirect
Date: Mon, 20 Dec 2021 06:36:10 GMT
Content-Type: text/html
Content-Length: 164
Connection: keep-alive
Location: https://gilotrif.com
X-Lagoon: bi2.amazee.io>gilotrif-com-master:nginx>
Set-Cookie: visid_incap_2283976=w0kAt/xIRHuc9nDkgH9udFokwGEAAAAAQUIPAAAAAADhIpJDr9st4vEJohiJAut1; expires=Tue, 20 Dec 2022 05:52:56 GMT; HttpOnly; path=/; Domain=.gilotrif.com
Set-Cookie: nlbi_2283976=tVkbDRchT0CgJ/gvCNFFjAAAAAD29J2NwWVSfgODoAzGfZYh; path=/; Domain=.gilotrif.com
Set-Cookie: incap_ses_1228_2283976=pF4oYTpBMi6PvvHGB7wKEVokwGEAAAAAvM4yPwg8nPrZFrFclNW/5w==; path=/; Domain=.gilotrif.com
Set-Cookie: ___utmvmlOBuwEyIZ=HyVfJwgepkd; path=/; Max-Age=900
Set-Cookie: ___utmvalOBuwEyIZ=nacoPie; path=/; Max-Age=900
Set-Cookie: ___utmvblOBuwEyIZ=lZu
XVLOealx: stU; path=/; Max-Age=900
X-CDN: Imperva
X-Iinfo: 8-127019-127020 NNNN CT(91 -1 0) RT(1639982170164 0) q(0 0 1 1) r(2 2) U6
HTTP/1.1 200 OK
Date: Mon, 20 Dec 2021 06:36:10 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
Cache-Control: max-age=0, must-revalidate, no-cache, no-store, s-maxage=0
Permissions-Policy: geolocation 'self';fullscreen 'self'
X-XSS-Protection: 1; mode=block
X-Content-Type-Options: nosniff
Strict-Transport-Security: max-age=5184000,preload
X-DNS-Prefetch-Control: off
X-Permitted-Cross-Domain-Policies: none
Access-Control-Allow-Origin: *
Access-Control-Allow-Headers: *
Access-Control-Allow-Methods: GET,POST,PUT,DELETE
X-Frame-Options: SAMEORIGIN
Set-Cookie: XSRF-TOKEN=eyJpdiI6ImI1cVU3eDdPc25VKzBsNmc5K3RXSEE9PSIsInZhbHVlIjoidm1TVmlRbG10T3NZREZuZm1PXC9Zd1wvTlBFQ3lYZEVwZ01MTmc3MzNnUFVEUmgrMUl1THB4ODZvVXNzcnlXRnlTIiwibWFjIjoiOGZhZTMwMTQ5ODYxYTM0MjlkZGQ3YzJiMGQxYmI0MjAxOWNiNGFiZmIyMWY2MjIwMTFjZWEzZDM5NDU2Zjc1MyJ9; expires=Mon, 20-Dec-2021 08:36:10 GMT; Max-Age=7200; path=/; secure; httponly
Set-Cookie: laravel_session=eyJpdiI6IlFsWWpiN29zQ0h3TTlJKzNEUTJKV3c9PSIsInZhbHVlIjoiSmkxWVh3aG1LS0ZxM0RDZFFMY2RIOWR2ZEVyU05WRTUyVU9cL29yMVArbkNSZGhDd1pMRTJ5YjlcL0hqSXdYYmZuIiwibWFjIjoiYjA5ZDQyYmY4NzVjZGY2NGIzNmE2MTM4MjYyNjlmYzc5OTFkNTA4YTMyMTgwNDEzMTk5ZmMwYzdlZTYzZDk5YiJ9; expires=Mon, 20-Dec-2021 08:36:10 GMT; Max-Age=7200; path=/; secure; httponly; samesite=none
X-LAGOON: bi2.amazee.io>gilotrif-com-master:nginx>nginx-579b74765c-5v2pt
Set-Cookie: visid_incap_2283976=ihMd6QIySsuGJlGwTYBWCFkkwGEAAAAAQUIPAAAAAABCQxoJUkbvmaKhDnWsoTDf; expires=Mon, 19 Dec 2022 13:45:13 GMT; HttpOnly; path=/; Domain=.gilotrif.com
Set-Cookie: nlbi_2283976=L9DuZACW6ypMoYkbCNFFjAAAAAAiKkScckfem4cqNiy9JMsl; path=/; Domain=.gilotrif.com
Set-Cookie: incap_ses_1466_2283976=7KxAMpWwsnL9cf1AVUdYFFokwGEAAAAAyEUAK6tNu2gBPZPDVqapWg==; path=/; Domain=.gilotrif.com
Set-Cookie: ___utmvmklBuwEyIZ=doQWEEauxlx; path=/; Max-Age=900
Set-Cookie: ___utmvaklBuwEyIZ=FccmFKR; path=/; Max-Age=900
Set-Cookie: ___utmvbklBuwEyIZ=KZC
XiEOnall: HtI; path=/; Max-Age=900
X-CDN: Imperva
X-Iinfo: 12-113073540-113073542 NNNN CT(84 88 0) RT(1639982169698 11) q(0 0 1 0) r(2 4) U6
|
gilotrif.com Whois Information
Domain Name: GILOTRIF.COM Registry Domain ID: 1772654159_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.nameshield.net Registrar URL: http://www.nameshield.net Updated Date: 2021-01-09T23:04:17Z Creation Date: 2013-01-11T11:27:33Z Registry Expiry Date: 2023-01-11T11:27:33Z Registrar: NAMESHIELD SAS Registrar IANA ID: 1251 Registrar Abuse Contact Email: abuse@nameshield.net Registrar Abuse Contact Phone: +33241182828 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NSA.PERF1.FR Name Server: NSB.PERF1.COM Name Server: NSC.PERF1.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-23T07:47:52Z <<< |